| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2506 |
| Trial ID | NCT04629729 |
| Disease | B-Cell Lymphoma | B-Cell Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | FT819 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | FT819 in Subjects With B-cell Malignancies |
| Year | 2020 |
| Country | United States |
| Company sponsor | Fate Therapeutics |
| Other ID(s) | FT819-101 |
| Cohort 1 | |||||||
|
|||||||